amlodipine has been researched along with Blood Pressure, Low in 25 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension." | 8.31 | 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. ( Abe, M; Fukuda, N; Hara, T; Ishizuka, M; Ito, H; Katakawa, M; Otsuka, N, 2023) |
| " Amlodipine, a dihydropyridine CCB, can cause prolonged hypotension in overdose." | 7.88 | A Case of Severe, Refractory Hypotension After Amlodipine Overdose. ( Chudow, M; Ferguson, K, 2018) |
| "A 49-year-old white woman with known bilateral early optic atrophy presented to our hospital with hypotension and obtundation following a known ingestion of 150 mg of amlodipine." | 7.85 | Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case report. ( Chick, G; Kao, R; Landry, Y; Leung, A, 2017) |
| "A case of acute poisoning with amlodipine with deep hypotension, transient oliguria and clinical signs of acute heart failure was described." | 7.71 | [Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine]. ( Feldman, R; Glińska-Serwin, M, 2001) |
| " Amlodipine is often favored clinically over other calcium channel blockers for its vascular selectivity and relative lack of negative ionotropy, once daily dosing and prolonged duration of effect." | 5.39 | Postoperative hypotension associated with amlodipine. ( Kadam, PG; Shah, VR, 2013) |
| "These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension." | 4.31 | 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. ( Abe, M; Fukuda, N; Hara, T; Ishizuka, M; Ito, H; Katakawa, M; Otsuka, N, 2023) |
| " Amlodipine, a dihydropyridine CCB, can cause prolonged hypotension in overdose." | 3.88 | A Case of Severe, Refractory Hypotension After Amlodipine Overdose. ( Chudow, M; Ferguson, K, 2018) |
| "A 49-year-old white woman with known bilateral early optic atrophy presented to our hospital with hypotension and obtundation following a known ingestion of 150 mg of amlodipine." | 3.85 | Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case report. ( Chick, G; Kao, R; Landry, Y; Leung, A, 2017) |
| " We report a case of persistent hypotension caused by intoxication of olmesartan and amlodipine." | 3.77 | [Case of olmesartan and amlodipine intoxication]. ( Ideno, S; Kobari, M; Nakada, T; Oiwa, T; Yaguchi, A, 2011) |
| "Amlodipine is a long-acting calcium channel blocker capable of producing hypotension and dysrhythmia in overdose." | 3.76 | Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data. ( Bakhireva, LN; Benson, BE; Spyker, DA; Troutman, WG; Watson, WA, 2010) |
| "A case of acute poisoning with amlodipine with deep hypotension, transient oliguria and clinical signs of acute heart failure was described." | 3.71 | [Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine]. ( Feldman, R; Glińska-Serwin, M, 2001) |
| " Third-standard-dose triple antihypertensive combination therapy demonstrated early effective BP control compared to third-standard-dose dual combination therapies, without increasing adverse drug reactions in patients with mild-to-moderate hypertension." | 3.30 | Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension. ( Cho, DK; Cho, GY; Cho, JM; Heo, JH; Hong, SJ; Jeong, MH; Jung, JA; Kim, DH; Kim, SH; Kim, SY; Kim, W; Kwon, K; Lee, HY; Lee, JB; Lim, SW; Park, K; Park, S; Pyun, WB; Rha, SW; Rhee, MY; Shin, J; Sung, KC, 2023) |
| "2 years in the VALUE trial (Valsartan Antihypertensive Long-Term Use Evaluation)." | 2.94 | Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers. ( Berge, E; Julius, S; Kjeldsen, SE; Liestøl, K; Mancia, G; Mehlum, MH; Parati, G; Rothwell, PM; Weber, MA; Wyller, TB, 2020) |
| "Midlife hypertension is an important risk factor for cognitive impairment and dementia, including Alzheimer's disease." | 1.91 | Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats. ( Bakker, ENTP; Coolen, BF; de Vos, J; Heijst, JA; Jongenelen, CAM; Naessens, DMP; Richard, E; Scholl, ER; Strijkers, GJ; Teunissen, CE; van der Wel, NN; VanBavel, E; Wilhelmus, MMM, 2023) |
| " Insulin was infused for a total of approximately 37 hours, most of which was dosed at 10 U/kg/hour; following discontinuation, serial serum insulin levels were drawn and remained at supraphysiologic levels for at least 24 hours and well above reference range for multiple days thereafter." | 1.56 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. ( Bangh, SA; Cole, JB; Corcoran, JN; Jacoby, KJ; Olives, TD, 2020) |
| " Amlodipine is often favored clinically over other calcium channel blockers for its vascular selectivity and relative lack of negative ionotropy, once daily dosing and prolonged duration of effect." | 1.39 | Postoperative hypotension associated with amlodipine. ( Kadam, PG; Shah, VR, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 6 (24.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, T | 1 |
| Xu, LL | 1 |
| Guo, PY | 1 |
| Shi, WT | 1 |
| Cheng, YQ | 1 |
| Liu, AJ | 1 |
| Naessens, DMP | 1 |
| de Vos, J | 1 |
| Richard, E | 1 |
| Wilhelmus, MMM | 1 |
| Jongenelen, CAM | 1 |
| Scholl, ER | 1 |
| van der Wel, NN | 1 |
| Heijst, JA | 1 |
| Teunissen, CE | 1 |
| Strijkers, GJ | 1 |
| Coolen, BF | 1 |
| VanBavel, E | 1 |
| Bakker, ENTP | 1 |
| Fukuda, N | 1 |
| Katakawa, M | 1 |
| Ito, H | 1 |
| Hara, T | 1 |
| Otsuka, N | 1 |
| Ishizuka, M | 1 |
| Abe, M | 1 |
| Sung, KC | 1 |
| Hong, SJ | 1 |
| Rhee, MY | 1 |
| Jeong, MH | 1 |
| Kim, DH | 1 |
| Lim, SW | 1 |
| Park, K | 1 |
| Lee, JB | 1 |
| Kim, SY | 1 |
| Cho, JM | 1 |
| Cho, GY | 1 |
| Heo, JH | 1 |
| Kim, SH | 1 |
| Lee, HY | 1 |
| Kim, W | 1 |
| Cho, DK | 1 |
| Park, S | 1 |
| Shin, J | 1 |
| Pyun, WB | 1 |
| Kwon, K | 1 |
| Rha, SW | 1 |
| Jung, JA | 1 |
| Mehlum, MH | 1 |
| Liestøl, K | 1 |
| Kjeldsen, SE | 1 |
| Wyller, TB | 1 |
| Julius, S | 1 |
| Rothwell, PM | 1 |
| Mancia, G | 1 |
| Parati, G | 1 |
| Weber, MA | 1 |
| Berge, E | 1 |
| Corcoran, JN | 1 |
| Jacoby, KJ | 1 |
| Olives, TD | 1 |
| Bangh, SA | 1 |
| Cole, JB | 1 |
| Chudow, M | 1 |
| Ferguson, K | 1 |
| Kao, R | 1 |
| Landry, Y | 1 |
| Chick, G | 1 |
| Leung, A | 1 |
| Zahed, NS | 1 |
| Hassanian-Moghaddam, H | 1 |
| Zamani, N | 1 |
| Raj, A | 1 |
| Panda, PK | 1 |
| Singh, SS | 1 |
| Bhatia, D | 1 |
| McDonald, MB | 1 |
| Tiyyagura, GK | 1 |
| Kondrich, J | 1 |
| Kadam, PG | 1 |
| Shah, VR | 1 |
| Brunette-Lawrey, E | 1 |
| Croft, F | 1 |
| Smith, SW | 1 |
| Ferguson, KL | 1 |
| Hoffman, RS | 3 |
| Nelson, LS | 1 |
| Greller, HA | 1 |
| Benson, BE | 1 |
| Spyker, DA | 1 |
| Troutman, WG | 1 |
| Watson, WA | 1 |
| Bakhireva, LN | 1 |
| Lugassy, DM | 1 |
| Martin, JA | 1 |
| Ideno, S | 1 |
| Nakada, T | 1 |
| Oiwa, T | 1 |
| Kobari, M | 1 |
| Yaguchi, A | 1 |
| Nimbalkar, SM | 1 |
| Patel, DV | 1 |
| Harris, NS | 1 |
| Aggarwal, C | 1 |
| Gupta, S | 1 |
| Thompson, TM | 1 |
| Bryant, SM | 1 |
| Lu, JJ | 1 |
| Kanagarajan, K | 1 |
| Marraffa, JM | 1 |
| Bouchard, NC | 1 |
| Krishnan, P | 1 |
| Stork, CM | 1 |
| Koch, AR | 1 |
| Vogelaers, DP | 1 |
| Decruyenaere, JM | 1 |
| Callens, B | 1 |
| Verstraete, A | 1 |
| Buylaert, WA | 1 |
| Cleophas, TJ | 1 |
| van der Meulen, J | 1 |
| van de Luit, L | 1 |
| Zwinderman, AH | 1 |
| Feldman, R | 1 |
| Glińska-Serwin, M | 1 |
3 trials available for amlodipine and Blood Pressure, Low
| Article | Year |
|---|---|
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Thera | 2023 |
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.
Topics: Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pre | 2020 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme | 1999 |
22 other studies available for amlodipine and Blood Pressure, Low
| Article | Year |
|---|---|
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Hypotension; Rats; Rats, Inbred SHR; T | 2023 |
Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Carotid Artery, Common; Hypertension; Hypote | 2023 |
5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats.
Topics: Aminolevulinic Acid; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Bupivacaine; Hype | 2023 |
Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Bradycardia; Calcium Channel Blockers; Drug Admi | 2020 |
A Case of Severe, Refractory Hypotension After Amlodipine Overdose.
Topics: Amlodipine; Blood Pressure; Calcium Channel Blockers; Drug Overdose; Fatal Outcome; Humans; Hypotens | 2018 |
Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case report.
Topics: Amlodipine; Blindness; Calcium Channel Blockers; Drug Overdose; Fat Emulsions, Intravenous; Female; | 2017 |
A Fatal Case of Amlodipine Toxicity Following Iatrogenic Hypercalcemia.
Topics: Adult; Amlodipine; Calcium Channel Blockers; Calcium Gluconate; Electrocardiography; Fatal Outcome; | 2018 |
Amlodipine (150 mg) Poisoning: A Case Study.
Topics: Adolescent; Amlodipine; Calcium Channel Blockers; Drug Overdose; Female; Humans; Hypotension; Shock; | 2018 |
Index of suspicion. Case 1: Fatigue, weakness, body aches, and metabolic alkalosis in a 15-year-old boy. Case 2: Refractory hypotension, tachycardia, hyperglycemia, and metabolic acidosis in an afebrile teen.
Topics: Acidosis; Adolescent; Alkalosis; Amlodipine; Calcium Channel Blockers; Diagnosis, Differential; Drug | 2013 |
Postoperative hypotension associated with amlodipine.
Topics: Amlodipine; Calcium Channel Blockers; Cholecystectomy, Laparoscopic; Humans; Hypotension; Male; Midd | 2013 |
Losartan and amlodipine overdose-Case Report of a patient with anuric renal failure prior to the onset of hypotension.
Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Anuria; Drug Overdose; Female; Humans; Hyp | 2016 |
Prolonged severe hypotension following combined amlodipine and valsartan ingestion.
Topics: Aged; Amlodipine; Antidotes; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Cardi | 2008 |
Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data.
Topics: Amlodipine; Calcium Channel Blockers; Child, Preschool; Databases, Factual; Dose-Response Relationsh | 2010 |
Amlodipine toxicity vs. exposure in children.
Topics: Amlodipine; Calcium Channel Blockers; Humans; Hypotension; Poison Control Centers | 2011 |
[Case of olmesartan and amlodipine intoxication].
Topics: Acid-Base Imbalance; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Calcium Gluconate; Drug Ov | 2011 |
Near fatal case of amlodipine poisoning in an infant.
Topics: Amlodipine; Calcium Channel Blockers; Drug Overdose; Glucose; Humans; Hypotension; Infant; Infusions | 2013 |
Case records of the Massachusetts General Hospital. Case 24-2006. A 40-year-old woman with hypotension after an overdose of amlodipine.
Topics: Adult; Amlodipine; Calcium; Calcium Channel Blockers; Cardiotonic Agents; Combined Modality Therapy; | 2006 |
Case 24-2006: a woman with hypotension after an overdose of amlodipine.
Topics: Amlodipine; Calcium Channel Blockers; Humans; Hypotension; Insulin; Poisoning | 2006 |
Case 24-2006: a woman with hypotension after an overdose of amlodipine.
Topics: Amlodipine; Calcium Channel Blockers; Contraindications; Humans; Hypotension; Intestines; Poisoning; | 2006 |
The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.
Topics: Adult; Amlodipine; Antidotes; Blood Pressure; Calcium Channel Blockers; Diazepam; Diltiazem; Drug Ov | 2007 |
Fatal intoxication with amlodipine.
Topics: Amlodipine; Fatal Outcome; Female; Humans; Hypotension; Middle Aged; Oxazepam | 1995 |
[Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine].
Topics: Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Drug Overdose; Female; Heart F | 2001 |